Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach
Authors not listed
US Department of Veterans Affairs · 1999
Abstract
This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (1999). Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach. <em>US Department of Veterans Affairs</em>. https://clinicaltrials.gov/study/NCT00018382
Vancouver
Anonymous. Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach. US Department of Veterans Affairs. 1999.
BibTeX
@misc{anon1999Insuli,
title = {Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach},
author = {Anonymous},
journal = {US Department of Veterans Affairs},
year = {1999},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Seoul National University Hospital 2014
Open access · US-GOV
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease
US Department of Veterans Affairs 1998
Open access · US-GOV
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Neuropeptides 2018
Citation only